Abstract
Considering the prevalence of 22q11.2 deletion syndrome (22q11.2 DS) of around 1:4,000 and of palatal abnormalities in 70 % of the cases of 22q11.2 DS and taking into account the Brazilian health system and its current situation of medical genetic services, this study aims to contribute to establish strategies for genetic diagnosis. The access to genetic testing at 11 services was investigated and samples from 100 patients with palatal abnormalities and suspicion of 22q11.2 DS were sent to a reference center. Laboratorial techniques included karyotyping, fluorescence in situ hybridization (FISH), and multiplex ligation-dependent probe amplification. Costs were also calculated. Disparities among centers for genetic diagnosis were evident, with remarkable regional differences. Some of the obstacles encountered were difficulties for families to show up for medical appointments, complementary evaluations, and for the clinics to send the samples to the reference center. A conclusive diagnosis was reached for 38 % of patients. Combination of karyotyping and FISH had better laboratorial cost-effectiveness. These results might represent the reality for the investigation of other genetic conditions. Clinical and laboratorial approaches herein presented could be adapted for use under different genetic conditions in the Brazilian health system, which has relatively limited financial and human resources. Suggestions for the rational implementation of genetic testing in developing countries are presented.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Notes
As part of the strategy adopted by the CFBP in 2009, a Cytogenetics Laboratory was implemented in the northeast (Universidade Estadual de Ciências da Saúde de Alagoas [UNCISAL], Maceio, Alagoas), with support by CNPq.
References
Bartsch O, Nemecková M, Kocárek E, Wagner A, Puchmajerová A, Poppe M, Ounap K, Goetz P (2003) DiGeorge/velocardiofacial syndrome: FISH studies of chromosomes 22q11 and 10p14, and clinical reports on the proximal 22q11 deletion. Am J Med Genet A117A(1):1–5
Brasil Ministério da Saúde (2010) SINASC (Sistema de Informações sobre nascidos vivos). Available at http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sinasc/cnv/nvuf.def. Accessed August 2012
Brasil Ministério da Saúde (2011) Coordenação Geral de Informações e Análises Epidemiológicas. Painel de Monitoramento da Mortalidade Infantil e Fetal. Available at http://svs.aids.gov.br/dashboard/mortalidade/infantil.show.mtw. Accessed 3 November 2011
Brunet A, Gabau E, Perich RM, Valdesoiro L, Brun C, Caballin MR, Guitart M (2006) Microdeletion and microduplication 22q11.2 screening in 295 patients with clinical features of DiGeorge/velocardiofacial syndrome. Am J Med Genet 140A:2426–2432
Castilla EE, Luquetti DV (2009) Brazil: public health genomics. Public Health Genomics 12:53–58
Daar AS, Berndtson K, Persad DL, Singer PA (2007) How can developing countries harness biotechnology to improve health? BMC Public Health 7:346
Elias PEM, Cohn A (2003) Health reform in Brazil: lessons to consider. Am J Public Health 93:44–48
Emanuel BS (2008) Molecular mechanisms and diagnosis of chromosome 22q11.2 rearrangements. Dev Disabil Res Rev 14(1):11–18
Fernández L, Lapunzina P, Arjona D, López Pajares I, García-Guereta L, Elorza D, Burgueros M, De Torres ML, Mori MA, Palomares M, García-Alix A, Delicado A (2005) Comparative study of three diagnostic approaches (FISH, STRs and MLPA) in 30 patients with 22q11.2 deletion syndrome. Clin Genet 68(4):373–378
Fontes MB, Almeida LN, Reis-Junior GO, Vieira-Filho IJ, Santos KM, Anjos FS, Andrade AK, Porciuncula CG, Oliveira MC, Pereira RM, Vieira TA, Viguetti-Campos NL, Gil-da-Silva-Lopes VL, Monlleo IL (2012) Local strategies to address health needs of individuals with oral clefts in Alagoas, Brazil. Cleft Palate Craniofac J. doi:10.1597/11-069
Gene Tests (2011) Available at http://www.ncbi.nlm.nih.gov/sites/GeneTests/. Accessed December 2011
Horovitz DD, Cardoso MH, Llerena JC Jr, de Mattos RA (2006) Birth defects in Brazil and health care: proposals for public policies in clinical genetics. Cad Saude Publica 22(12):2599–2609
Horovitz DD, de Faria Ferraz VE, Dain S, Marques-de-Faria AP (2012) Genetic services and testing in Brazil. J Community Genet (in press)
IBGE (2010) Instituto Brasileiro de Geografia e Estatística. Produto Interno Bruto a preços correntes e Produto Interno Bruto per capita segundo as Grandes Regiões, as Unidades da Federação e os municípios—2005–2009. Available at http://www.ibge.gov.br/home/estatistica/economia/pibmunicipios/2005_2009/tabelas_pdf/tab01.pdf. Accessed August 2012
Jehee FS, Takamori JT, Medeiros PF, Pordeus AC, Latini FR, Bertola DR, Kim CA, Passos-Bueno MR (2011) Using a combination of MLPA kits to detect chromosomal imbalances in patients with multiple congenital anomalies and mental retardation is a valuable choice for developing countries. Eur J Med Genet 54(4):e425–e432
Katzman PJ, Wang B, Sawhney M, Wang N (2005) Differential detection of deletion 22q11.2 syndrome by specialty and indication. Pediatr Dev Pathol 8(5):557–567
Knoppers BM, Leroux T, Doucet H, Godard B, Laberge C, Stanton-Jean M, Fortin S, Cousineau J, Monardes C, Girard N, Levesque L, Durand C, Farmer Y, Dion-Labrie M, Bouthillier ME, Avard D (2010) Framing genomics, public health research and policy: points to consider. Public Health Genomics 13(4):224–234
Kohonen-Corish MR, Al-Aama JY, Auerbach AD, Axton M, Barash CI, Bernstein I, Béroud C, Burn J, Cunningham F, Cutting GR, den Dunnen JT, Greenblatt MS, Kaput J, Katz M, Lindblom A, Macrae F, Maglott D, Möslein G, Povey S, Ramesar R, Richards S, Seminara D, Sobrido MJ, Tavtigian S, Taylor G, Vihinen M, Winship I, Cotton RG, Human Variome Project Meeting (2010) How to catch all those mutations—the report of the third Human Variome Project Meeting, UNESCO Paris. Hum Mutat 31(12):1374–1381
Marques-de-Faria AP, Ferraz VE, Acosta AX, Brunoni D (2004) Clinical genetics in developing countries: the case of Brazil. Community Genet 7(2–3):95–105
McDonald-McGinn DM, Sullivan KE (2011) Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore) 90(1):1–18
Monlleó IL, Gil-da-Silva-Lopes VL (2006) Brazil’s Craniofacial Project: genetic evaluation and counseling in the Reference Network for Craniofacial Treatment. Cleft Palate Craniofac J 43(5):577–579
Monlleó IL, Mossey PA, Gil-da-Silva-Lopes VL (2009) Evaluation of craniofacial care outside the Brazilian reference network for craniofacial treatment. Cleft Palate Craniofac J 46(2):204–211
Oh AK, Workman LA, Wong GB (2007) Clinical correlation of chromosome 22q11.2 fluorescent in situ hybridization analysis and velocardiofacial syndrome. Cleft Palate Craniofac J 44(1):62–66
Ruiter EM, Bongers EM, Smeets DF, Kuijpers-Jagtman AM, Hamel BC (2003) No justification of routine screening for 22q11 deletions in patients with overt cleft palate. Clin Genet 64(3):216–219
Shprintzen RJ (2008) Velo-cardio-facial syndrome: 30 years of study. Developmental Disabilities 14:3–10
Travassos C, de Oliveira EXG, Viacava F (2006) Desigualdades geográficas e sociais no acesso aos serviços de saúde no Brasil: 1998 e 2003. Cien Saude Colet 11(4):975–986
WHO—World Health Organization (2002) Global strategies to reduce the health-care burden of craniofacial anomalies. WHO, Geneva. Available at http://www.who.int/genomics/about/en/cfa1-3.pdf
WHO—World Health Organization (2006) Medical genetic services in developing countries. The ethical, legal and social implications of genetic testing and screening. Human Genetics, Chronic Diseases and Health Promotion, WHO, Geneva. Available at http://www.who.int/genomics/publications/GTS-MedicalGeneticServices-oct06.pdf
Yang C, Zhu X, Yi L, Shi Z, Wang H, Hu Y, Wang Y (2009) Comparative study of three PCR-based copy number variant approaches, CFMSA, M-PCR, and MLPA, in 22q11.2 deletion syndrome. Genet Test Mol Biomarkers 13(6):803–808
Acknowledgments
The authors are grateful to the patients and their families, and to all the participant clinical geneticists and institutions. This study was supported with funding from the CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico (# 01300.000433/2008-00 and #502438/2010-0), FAPESP - Fundação de Amparo a Pesquisa do Estado de São Paulo (#2008/50421-4, # 2008/096574; # 2009/09507-5 and 2009/08756-1) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vieira, T.P., Sgardioli, I.C. & Gil-da-Silva-Lopes, V.L. Genetics and public health: the experience of a reference center for diagnosis of 22q11.2 deletion in Brazil and suggestions for implementing genetic testing. J Community Genet 4, 99–106 (2013). https://doi.org/10.1007/s12687-012-0123-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12687-012-0123-z